PRN PharmaFarm’s mission is to fight blindness. Dr. Stewart, founder, is an ophthalmic development strategist who identifies promising start-ups by assisting in fundraising and bringing their medicines to market. Since 2010 Dr. Stewart has assisted start-ups with their development processes. In that role he has collaborated with a number of start-ups in developing their medicines, reviewed over 60 requests for funding, published in the area of ophtha start-up business and has many years’ experience working with the pharmaceutical industry. Together with his extensive network of professional colleagues he can help you evaluate your medicine in relation to the marketplace and assist you in starting your company. LATEST DISCOVERY - Dr. Stewart is serving as an advisor to Premark Pharma, based in Switzerland, and their novel blepharitis product. DR STEWART BROUGHT ENCORE VISION TO INVESTORS - Dr. Stewart envisioned Encore Vision’s presbyopia product as a potentially rewarding investment. Novartis recently acquired Encore Vision based on early clinical data.